… -deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
H Hu, L Kang, J Zhang, Z Wu, H Wang… - The Lancet …, 2022 - thelancet.com
… whether neoadjuvant toripalimab with or without celecoxib … colorectal cancers, we found the
best estimates of the proportion of … , toripalimab in combination with celecoxib compared with …
best estimates of the proportion of … , toripalimab in combination with celecoxib compared with …
[HTML][HTML] An overview of the BOIN design and its current extensions for novel early-phase oncology trials
R Ananthakrishnan, R Lin, C He, Y Chen, D Li… - … Clinical Trials …, 2022 - Elsevier
… the optimal biological dose (OBD) based on safety and efficacy. BOIN designs provide a
complete suite for dose finding in early phase trials… of a combination therapy to determine either …
complete suite for dose finding in early phase trials… of a combination therapy to determine either …
BOIN12: Bayesian optimal interval phase I/II trial design for utility-based dose finding in immunotherapy and targeted therapies
… dose for treating patients. For these novel therapies, the objective of dose-finding trials is to
identify the optimal biologic dose (OBD) … to the methotrexate plus erlotinib plus celecoxib trial. …
identify the optimal biologic dose (OBD) … to the methotrexate plus erlotinib plus celecoxib trial. …
COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers
… These include determining the optimal dose and duration of … chemotherapy drugs, such
as biological alkylating agents, anti-… Vandetanib and Celecoxib combination therapy was first …
as biological alkylating agents, anti-… Vandetanib and Celecoxib combination therapy was first …
[HTML][HTML] Short-Term Celecoxib Promotes Bone Formation without Compromising Cefazolin Efficacy in an Early Orthopaedic Device-Related Infection: Evidence from a …
… the efficacy of celecoxib is enhanced when combined with … short-term use of celecoxib offered
the best option for minimizing … , Infection biology group involved in this study. RISystem AG, …
the best option for minimizing … , Infection biology group involved in this study. RISystem AG, …
Intra-articular multifunctional celecoxib loaded hyaluronan nanocapsules for the suppression of inflammation in an osteoarthritic rat model
RI El-Gogary, MA Khattab, H Abd-Allah - International journal of …, 2020 - Elsevier
… formulation aimed to combine the beneficial … the optimized hyaluronan nanocapsules
formulation showed the superiority of the prepared celecoxib nanocapsules compared to celecoxib …
formulation showed the superiority of the prepared celecoxib nanocapsules compared to celecoxib …
Modeling adult COX‐2 cerebrospinal fluid pharmacokinetics to inform pediatric investigation
… an initial celecoxib of 6 mg kg −1 with a maintenance dose celecoxib 3 … This type of nonlinear
relationship with a maximum effect is … benefits of combination therapy (eg, celecoxib and …
relationship with a maximum effect is … benefits of combination therapy (eg, celecoxib and …
Metronomic therapy in pediatric oncology: a snapshot
R Pramanik, S Bakhshi - Pediatric Blood & Cancer, 2019 - Wiley Online Library
… or in combination with other nonchemotherapeutic agents such as celecoxib and thalidomide…
Future preclinical studies should focus on determination of optimum biological dosage and …
Future preclinical studies should focus on determination of optimum biological dosage and …
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3
ME Halatsch, RE Kast, G Karpel-Massler… - Neuro-Oncology …, 2021 - academic.oup.com
… The analgesic celecoxib has long been shown to have … encouraging results in combination
with low-dose temozolomide. The … We used the best overall response, ie, the best response …
with low-dose temozolomide. The … We used the best overall response, ie, the best response …
Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity
… Bayesian modelling to identify the optimal biological dose of methotrexate in combination with
erlotinib and celecoxib on the … A dose of 9 mg/m2 of methotrexate weekly was identified as …
erlotinib and celecoxib on the … A dose of 9 mg/m2 of methotrexate weekly was identified as …